Suppr超能文献

血管内皮生长因子受体-2(Flk-1/KDR)在发育中的小鼠胚胎以及妊娠早期(第4天至第7天)母体子宫支持组织中的细胞特异性表达。

Cell Specific Expression of Vascular Endothelial Growth Factor Receptor-2 (Flk-1/KDR) in Developing Mice Embryo and Supporting Maternal Uterine Tissue during Early Gestation (D4-D7).

作者信息

Das Dimpimoni, Saikia Purba J, Gowala Upasa, Sarma Hirendra N

机构信息

Molecular Endocrinology and Reproductive Biology Research Laboratory, Department of Zoology, Rajiv Gandhi University, Itanagar, Arunachal Pradesh, India.

Department of Zoology, Dhemaji College, Dhemaji, Assam, India. Email:

出版信息

Int J Fertil Steril. 2021 Apr;15(2):148-157. doi: 10.22074/IJFS.2021.134530. Epub 2021 Mar 11.

Abstract

BACKGROUND

Vascular endothelial growth factor (VEGF) and the corresponding receptors play key role in vasculogenesis and angiogenesis processes. VEGF is one of the prime candidates in regulating embryo implantation by increasing vascular permeability. VEGF receptor-2, also called Flk-1/KDR, is one of the prime receptor which is actively involved in the execution of various functions of VEGF. However, precise role of this receptor during early gestation period is yet to be addressed. In the present study, expression of Flk-1/KDR during peri-implantation mice uterus as well as fetal-maternal tissues from day 4-day 7 (D4-D7) of gestation was investigated.

MATERIALS AND METHODS

In this experimental study, localization of Flk-1/KDR was investigated by immunohistochemistry and immunofluorescence techniques, in paraffin embedded tissue sections. Flk-1/KDR protein and mRNA expressions were investigated by western blotting and quantitative reverse transcription polymerase chain reaction (qRT-PCR), respectively. Effects of ovarian steroids on expression of Flk-1/KDR were also assessed by estrogen and progesterone antagonist treatment.

RESULTS

Uterine tissue on D4 showed strong expression of Flk-1/KDR in luminal and uterine glandular epithelium. On D5 and D6, differential expression of Flk-1/KDR was evidenced in certain cell types of the embryo, maternal tissues and fetal-maternal interface with varied intensity. Flk-1/KDR was specifically expressed in the ectoplacental cone (EPC) and various cells of the embryo on D7. Flk-1/KDR expression was not evidenced in the estradiol-17β (E2) and progesterone (P4) antagonist treated uterus. Western blotting result revealed presence of Flk-1/KDR protein in the all gestation days, except antagonist treated uterus. qRT-PCR analysis showed significant increase of mRNA transcript on D6 and D7.

CONCLUSION

Spatial-temporal expression of Flk-1/KDR during peri-implntation period in mice uterus especially in the feto-maternal interface was observed. This spatio-temporal specificity as well as increased expression of Flk-1/KDR could be one of the determinants for establishment of fetal-maternal cross talk during the critical period of development.

摘要

背景

血管内皮生长因子(VEGF)及其相应受体在血管生成和血管形成过程中起关键作用。VEGF是通过增加血管通透性来调节胚胎着床的主要候选因子之一。VEGF受体-2,也称为Flk-1/KDR,是积极参与VEGF各种功能执行的主要受体之一。然而,该受体在妊娠早期的确切作用尚待阐明。在本研究中,研究了Flk-1/KDR在围着床期小鼠子宫以及妊娠第4天至第7天(D4-D7)的母胎组织中的表达情况。

材料与方法

在本实验研究中,通过免疫组织化学和免疫荧光技术,在石蜡包埋的组织切片中研究Flk-1/KDR的定位。分别通过蛋白质印迹法和定量逆转录聚合酶链反应(qRT-PCR)研究Flk-1/KDR蛋白和mRNA表达。还通过雌激素和孕激素拮抗剂处理评估卵巢类固醇对Flk-1/KDR表达的影响。

结果

第4天子宫组织在腔上皮和子宫腺上皮中显示出强烈的Flk-1/KDR表达。在第5天和第6天,在胚胎、母体组织和母胎界面的某些细胞类型中,Flk-1/KDR存在不同强度的差异表达。第7天,Flk-1/KDR在胎盘外锥体(EPC)和胚胎的各种细胞中特异性表达。在雌二醇-17β(E2)和孕激素(P4)拮抗剂处理的子宫中未发现Flk-1/KDR表达。蛋白质印迹结果显示,除拮抗剂处理的子宫外,在所有妊娠天数均存在Flk-1/KDR蛋白。qRT-PCR分析显示,第6天和第7天mRNA转录本显著增加。

结论

观察到Flk-1/KDR在小鼠子宫围着床期,特别是在母胎界面的时空表达。这种时空特异性以及Flk-1/KDR表达的增加可能是发育关键期母胎相互作用建立的决定因素之一。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验